A decade and genome of change by Garvey, Clare
Ten  years  ago,  Bill  Clinton,  the  then  US  president, 
announced at an historic event at the White House that 
the  international  Human  Genome  Project  and  Celera 
Genomics corporation had completed the initial draft of 
the human genome. President Clinton pledged the US’s 
commitment to continue to translate this genomic advance 
into  healthcare  and  therapeutic  strategies,  as  well  as 
protecting private genetic information. Little did he know 
of the impending cuts in exactly this area during the Bush 
years - ah, but let’s not go there. The genomics field since 
then has progressed at a phenomenal rate, with advances 
in the field being nothing short of monu  mental.
At around the same time as this historic announcement, 
Genome Biology [1] was launched. This new journal was 
quite unlike other journals in that it was open access and 
published  online.  In  an  accompanying  column  to  this 
editorial,  Greg  Petsko  [2],  Genome  Biology’s  long-term 
and  beloved-of-many  columnist,  discusses  Genome 
Biology’s launch, in addition to charting our success and 
the unique approach that has seen Genome Biology, in a 
relatively short period of time, take its place as a premier 
journal  for  genomics  research.  To  mark  some  of  the 
developments in the genomics field in the past decade, 
and to celebrate Genome Biology’s tenth birthday, we have 
commissioned a series of reviews focusing on key areas 
from the last ten years, ranging from the human micro-
biome  to  the  cancer  genome  projects.  The  themes  of 
these reviews will also be discussed at Genome Biology’s 
inaugural conference, which is being hosted jointly with 
our  sister  journal,  Genome  Medicine  [3],  in  Boston  in 
October [4].
Technological developments over the past decade have 
been the catalyst of innovation and progress, driving the 
genomics  field  forward  at  a  dizzying  pace.  Along  with 
these technological advances have come some revisions 
of the very gene count estimates that were announced ten 
years ago. Strikingly, current estimates are nowhere near 
the original 40,000 genes that humans were estimated to 
have.  In  his  review  entitled  ‘Between  a  chicken  and  a 
grape:  estimating  the  number  of  human  genes’  Steven 
Salzberg  [5]  reveals  that  current  estimates  of  the  true 
human gene count are closer to 20,000. So why has the 
estimated  gene  count  dropped  so  dramatically?  The 
advent of computational gene prediction and comparative 
genome mapping methods is largely responsible for the 
revision and, more recently, technological advances that 
have allowed small RNAs and alternative splice forms to 
be identified have also played a part. Salzberg predicts 
similar gene count estimate revisions for the chicken and 
grape genomes to those seen for the human genome.
The study of individual genes is now considered to be 
reductionist  though;  it  is  now  in  vogue  to  consider  a 
more systems-led approach, whereby all protein-protein 
interactions are documented and, on top of this, trans-
criptional, metabolomic and even environmental input is 
layered, providing a multidimensional readout of a cell’s 
activity. The rise of the systems biology field is outlined in 
a review by Nevan Krogan and Michael Fischbach [6]. In 
a similar vein, it is now apparent that we are not simply 
the sum of our genes. The contribution to our develop-
ment  and  immunity  from  bacterial  communities  that 
reside  in  the  human  body  is  relatively  unknown.  The 
Human Microbiome Project (HMP) [7] and the MetaHit 
consortia [8] aim to categorize these microbial commu-
nities and their effect on human health. Rob Knight [9] of 
the HMP discusses the sequencing depth that is needed 
to  map  variation  in  the  human  microbial  ecosystem 
between and within individuals.
Various  cancer  genome  projects,  such  as  the  Cancer 
Genome Atlas [10] and the International Cancer Genome 
Consortium [11], have over the past few years started to 
reveal mutational signatures for various cancers that will 
aid targeted treatment and which will provide insights at 
the stage of diagnosis. In addition, certain cancers, such 
as acute myeloid leukemia (AML), are being sequenced 
and compared with the normal genome of that patient to 
identify disease-causing mutations. These advances have 
been  made  mostly  through  huge  developments  in 
Abstract
Innovations in genomic technologies have generated 
huge advances in biomedical research over the last 
decade.
© 2010 BioMed Central Ltd
A decade and genome of change
Clare Garvey, Editor, Genome Biology*
EDITORIAL
*Correspondence: Clare.Garvey@genomebiology.com 
Genome Biology, BioMed Central, Gray’s Inn Road, London, WC1X 8HL, UK
Garvey Genome Biology 2010, 11:120 
http://genomebiology.com/2010/11/5/120
© 2010 BioMed Central Ltdsequencing  technologies.  Elaine  Mardis  [12]  discusses 
the  mutations  and  tumor-specific  alterations  that  have 
been  identified  using  next  generation  platforms  and 
which  have  revolutionized  clinical  diagnosis  of  cancer 
and subsequent therapies. As with all large consortium 
efforts, vast quantities of sequencing data are generated 
and, eventually, one has to address the issue of what to do 
with all of the data. How much should be stored and how 
can  these  data  be  readily  accessed  in  an  efficient  way, 
while  at  the  same  time  protecting  genetic  privacy,  as 
promised by Clinton ten years ago? Lincoln Stein [13] 
discusses how cloud computing provides the solution to 
these hurdles. The doubling time to generate such data 
now outstrips the rate at which institutes can upgrade 
data  storage  facilities.  The  cost  of  sequencing  has  also 
dropped  dramatically  compared  with  the  cost  of  data 
storage;  bizarrely,  it  is  now  reasonable  to  consider  re-
sequencing a sample instead of storing the raw data from 
the  original  read.  Cloud  computing  is  the  future  for 
bioinformatics analyses: instead of the data user moving 
the  data  to  the  compute  cluster,  the  user  moves  the 
compute cluster to the data. Genetic privacy can also be 
protected,  as  encrypted  data  are  stored  in  the  cloud 
where the analysis is run. Currently, such data are stored 
in restricted access databases.
In addition to Eugene Koonin’s review [14] on how the 
revolution  in  sequencing  technologies  has  provided 
evolutionary insights into the tree of life and a review by 
Robert Plenge [15] that discusses the success of genome-
wide association studies for determining the genetic basis 
of autoimmune diseases, overall, these reviews mark key 
genomic developments in the past ten years.
So here we are, ten years on from the announcement 
that  the  human  genome  had  been  sequenced.  Rather 
than considering this as an end point, however, we are 
now looking forward to a future with almost more data 
than  we  know  what  to  do  with  and  advances  in  our 
under  standing  of  human  biology  and  disease  that  will 
surely affect everyone. It seems that Clinton’s pledge to 
drive  forward  research  and  develop  translational 
therapies will be realized and that momentous occasion 
ten  years  ago  was  just  the  start  of  certainly  the  most 
exciting time in biological research.
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